At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4230 Passenger Ground Transportation
Market Closed 11-08 16:00:00 EST
2,100.33
-29.36
-1.38%
High2,140.55Low2,086.19Vol75.86M
Open2,129.59D1 Closing2,129.69Amplitude2.55%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O2.13BT/O Rate--Tradable Shares0.00
P/B7.824307ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
'It's a very ugly American trait': I cried foul when basic-economy passengers grabbed premium-economy seats. The airline has finally shown me respect.
Dow Jones  ·  11-10 21:01
'It's a very ugly American trait': I cried foul when basic-economy passengers grabbed premium-economy seats. The airline has finally shown me respect.
A Buy Antithesis For Grab Holdings
seekingalpha  ·  11-10 19:13
A Buy Antithesis For Grab Holdings
Grab This Undervalued Token Before It Skyrockets 2,000% and Reaches a $100B Market Cap
CoinMarketCap  ·  11-10 06:34
Grab This Undervalued Token Before It Skyrockets 2,000% and Reaches a $100B Market Cap
Some Uber and Lyft drivers are asking riders to avoid the apps and pay in cash
businessinsider.com  ·  11-09 18:12
Some Uber and Lyft drivers are asking riders to avoid the apps and pay in cash
The Score: Warner Bros. Discovery, JPMorgan Chase, Sony and More Stocks That Defined the Week -- WSJ
Dow Jones  ·  11-09 06:30
The Score: Warner Bros. Discovery, JPMorgan Chase, Sony and More Stocks That Defined the Week -- WSJ
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
MT Newswires Live  ·  11-09 05:53
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
GlobeNewswire  ·  11-09 05:23
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
GlobeNewswire  ·  11-09 05:01
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
Is Uber Technologies, Inc. (UBER) The Best Stock Under $100 To Invest In?
Insider Monkey  ·  11-09 03:51
Is Uber Technologies, Inc. (UBER) The Best Stock Under $100 To Invest In?
Workers Win Sick Leave and Union Perks. Tipped Workers Await Trump's Promise. -- Barrons.com
Dow Jones  ·  11-09 03:23
Workers Win Sick Leave and Union Perks. Tipped Workers Await Trump's Promise. -- Barrons.com
Positive Outlook for Autolus Therapeutics Amid Upcoming PDUFA Review and CAR-T Advancements
TIPRANKS  ·  11-09 01:15
Positive Outlook for Autolus Therapeutics Amid Upcoming PDUFA Review and CAR-T Advancements
Zoomcar Shares Decline After Closing of $9.2 Million Private Placement
MT Newswires Live  ·  11-09 01:03
Zoomcar Shares Decline After Closing of $9.2 Million Private Placement
BRIEF-Carisma Unveils Pre-Clinical Data On Anti-GPC3 In Vivo CAR-M Therapy For Hepatocellular Carcinoma
Reuters  ·  11-08 20:39
BRIEF-Carisma Unveils Pre-Clinical Data On Anti-GPC3 In Vivo CAR-M Therapy For Hepatocellular Carcinoma
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
PR Newswire  ·  11-08 20:30
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Bolt drivers win UK tribunal claim over 'workers' employment status
Reuters  ·  11-08 20:02
Bolt drivers win UK tribunal claim over 'workers' employment status
Uber Q3 2024: One-Time Speed Bump; Super App Ambition Unshaken
seekingalpha  ·  11-08 20:00
Uber Q3 2024: One-Time Speed Bump; Super App Ambition Unshaken
3 US Stocks That Might Be Priced Below Their Estimated Value
Simply Wall St.  ·  11-08 18:06
3 US Stocks That Might Be Priced Below Their Estimated Value
Allogene Therapeutics Advances CAR T Therapies
TIPRANKS  ·  11-08 12:40
Allogene Therapeutics Advances CAR T Therapies
CAR Group Issues New Performance Rights
TIPRANKS  ·  11-08 10:48
CAR Group Issues New Performance Rights
BRIEF-Zoomcar Announces Closing Of $9.15 Million Private Placement
Reuters  ·  11-08 07:35
BRIEF-Zoomcar Announces Closing Of $9.15 Million Private Placement

Introduction

Company Name.
BK4230
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--